The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADVERUM BIOTECHNOLOGIES INC | COM NEW | 00773U207 | 3,715,829 | 541,666 | SH | SOLE | 541,666 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 8,964,789 | 357,733 | SH | SOLE | 357,733 | 0 | 0 | ||
BIOHAVEN LTD | COM | G1110E107 | 16,312,728 | 469,972 | SH | SOLE | 469,972 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 18,403,963 | 497,270 | SH | SOLE | 497,270 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 11,242,350 | 1,245,000 | SH | SOLE | 1,245,000 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757206 | 677,297 | 56,725 | SH | SOLE | 56,725 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 6,663,409 | 790,440 | SH | SOLE | 790,440 | 0 | 0 | ||
DIANTHUS THERAPEUTICS INC | COM | 252828108 | 31,909,134 | 1,232,965 | SH | SOLE | 1,232,965 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 61,016,149 | 2,610,875 | SH | SOLE | 2,610,875 | 0 | 0 | ||
ENTRADA THERAPEUTICS INC | COM | 29384C108 | 62,819,401 | 4,408,379 | SH | SOLE | 4,408,379 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 12,756,753 | 5,405,404 | SH | SOLE | 5,405,404 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 435,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 6,677,274 | 572,665 | SH | SOLE | 572,665 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 2,623,050 | 1,305,000 | SH | SOLE | 1,305,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 12,413,303 | 282,313 | SH | SOLE | 282,313 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 14,994,880 | 797,600 | SH | SOLE | 797,600 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 14,062,400 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
Q32 BIO INC | COM | 746964105 | 4,523,292 | 251,994 | SH | SOLE | 251,994 | 0 | 0 | ||
RALLYBIO CORP | COM | 75120L100 | 4,865,170 | 3,630,724 | SH | SOLE | 3,630,724 | 0 | 0 | ||
SCPHARMACEUTICALS INC | COM | 810648105 | 5,222,814 | 1,200,647 | SH | SOLE | 1,200,647 | 0 | 0 | ||
SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | 9,047,800 | 476,200 | SH | SOLE | 476,200 | 0 | 0 | ||
SKYE BIOSCIENCE INC | COM NEW | 83086J200 | 81,537,835 | 10,179,505 | SH | SOLE | 10,179,505 | 0 | 0 | ||
TECTONIC THERAPEUTIC INC | COM | 878972108 | 10,648,250 | 646,524 | SH | SOLE | 646,524 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 15,019,375 | 939,298 | SH | SOLE | 939,298 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 12,593,056 | 237,560 | SH | SOLE | 237,560 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 9,583,101 | 736,595 | SH | SOLE | 736,595 | 0 | 0 | ||
VOR BIOPHARMA INC | COM | 929033108 | 6,361,723 | 6,361,723 | SH | SOLE | 6,361,723 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 2,004,100 | 490,000 | SH | SOLE | 490,000 | 0 | 0 |